15.16
Schlusskurs vom Vortag:
$14.97
Offen:
$14.94
24-Stunden-Volumen:
110.66K
Relative Volume:
0.64
Marktkapitalisierung:
$1.02B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-46.13M
KGV:
-18.66
EPS:
-0.8123
Netto-Cashflow:
$-34.10M
1W Leistung:
-0.39%
1M Leistung:
-0.92%
6M Leistung:
-19.02%
1J Leistung:
-9.87%
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie PLSE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PLSE
Pulse Biosciences Inc
|
15.16 | 1.02B | 0 | -46.13M | -34.10M | -0.8123 |
![]()
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
2021-07-27 | Eingeleitet | Stephens | Overweight |
2021-03-11 | Eingeleitet | Maxim Group | Buy |
2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
What analysts say about Pulse Biosciences Inc. stockUnmatched market gains - jammulinksnews.com
Is Pulse Biosciences Inc. a good long term investmentExponential wealth increase - printweek.in
What drives Pulse Biosciences Inc. stock priceDynamic portfolio growth - Autocar Professional
Pulse Biosciences Inc. Stock Analysis and ForecastRapid portfolio appreciation - printweek.in
Should I buy Pulse Biosciences Inc. stock before earningsFree Deep Market Trend Analysis - Newser
How Pulse Biosciences Inc. stock performs during market volatilityDaily Top Gainers - beatles.ru
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 - BioSpace
Pulse Biosciences Appoints New VP of Accounting - The Globe and Mail
What makes Pulse Biosciences Inc. stock price move sharplyBreakout Momentum Alerts - Newser
Why Pulse Biosciences Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Pulse Biosciences appoints Steven T. Weber as principal accounting officer - Investing.com
Don't Ignore The Insider Selling In Pulse Biosciences - 富途牛牛
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential - Investing.com Canada
Oppenheimer initiates coverage on Pulse Biosciences with an Outperform rating, $22 PT. - AInvest
Oppenheimer & Co. Inc. Sells 5,000 Shares of Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
(PLSE) Long Term Investment Analysis - news.stocktradersdaily.com
GAMMA Investing LLC Boosts Stock Position in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Farther Finance Advisors LLC Has $143,000 Stock Holdings in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Insider Sell: Darrin Uecker Sells 30,000 Shares of Pulse Bioscie - GuruFocus
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Nuveen Asset Management LLC Has $990,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
BNP Paribas Financial Markets Has $35,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Bank of America Corp DE Has $13.73 Million Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):